Published in N Z Med J on July 09, 1980
Coronary prognostic index for predicting survival after recovery from acute myocardial infarction. Lancet (1970) 3.58
Prognosis after myocardial infarction. Six-year follow-up. Br Heart J (1974) 2.17
Practolol in the treatment of cardiac dysrhythmias due to acute myocardial infarction. Lancet (1969) 2.15
Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet (1983) 1.91
Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction. Lancet (1969) 1.88
Solar neutrinos: proposal for a new test. Science (1976) 1.37
Lupus anticoagulant in pregnancy. Br J Obstet Gynaecol (1984) 1.30
Characterization of the "border zone" in acute regional ischemia in the dog. Am J Cardiol (1977) 1.28
Long term prognosis following treatment in coronary-care unit. Aust N Z J Med (1973) 1.22
Biochemical aspects of arrhythmogenesis and ventricular fibrillation. Am J Cardiol (1979) 1.18
Conduction disturbances due to anteroseptal myocardial infarction and their treatment by endocardial pacing. Am Heart J (1972) 1.18
Antihypertensive actions of diuretics. Comparative study of an aldosterone antagonist and a thiazide, alone and together. JAMA (1968) 1.16
Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am J Cardiol (1979) 1.13
Evaluation of blood flow velocity in the ascending aorta and main pulmonary artery of normal subjects by Doppler echocardiography. Am Heart J (1984) 1.09
The management of metastases to eye and orbit from carcinoma of the breast. Aust N Z J Ophthalmol (1990) 1.08
Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. J Rheumatol (1988) 1.07
Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction. Nature (1975) 1.07
Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res (1978) 1.04
Experimental myocardial infarction with left ventricular failure in the isolated perfused rat heart. Effects of isoproterenol and pacing. J Mol Cell Cardiol (1975) 1.04
Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. N Z Med J (1981) 1.02
Ventricular fibrillation threshold and vulnerable period in the isolated perfused rat heart. Cardiovasc Res (1975) 1.02
Chorea gravidarum associated with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy. Case report. Br J Obstet Gynaecol (1983) 0.99
Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs. Lancet (1976) 0.96
Prognosis following acute myocardial infarction. N Z Med J (1973) 0.94
Distribution of myocardial blood flow before and after coronary artery ligation in the baboon. Relation to early ventricular fibrillation. Cardiovasc Res (1974) 0.94
Idioventricular rhythm complicating acute myocardial infarction. Br Heart J (1970) 0.92
Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am Heart J (1975) 0.91
The lupus-anticoagulant: clinical and obstetric implications. N Z Med J (1984) 0.90
Amiodarone in long term management of refractory cardiac tachyarrhythmias. N Z Med J (1981) 0.89
Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade. S Afr Med J (1979) 0.89
Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart. Cardiovasc Res (1981) 0.89
The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart. J Clin Invest (1978) 0.89
Improving medical meetings. III--Diversify the format of conference sessions. Br Med J (Clin Res Ed) (1983) 0.88
Cyclic AMP as a determinant of vulnerability to ventricular fibrillation in the isolated rat heart. Cardiovasc Res (1976) 0.86
Lupus anticoagulant and pregnancy. Am J Obstet Gynecol (1985) 0.86
Oesophageal ulceration due to slow-release potassium in the presence of left atrial enlargement. N Z Med J (1979) 0.85
Amiodarone-induced torsades de pointes. Eur Heart J (1986) 0.84
Hypertension in pregnancy. Pathophysiology and management. Drugs (1984) 0.84
Cyclic A.M.P. and arrhythmias revisited. Lancet (1978) 0.83
Extensive pulmonary embolism associated with lupus anticoagulant. N Z Med J (1985) 0.83
Letter: Are free fatty acids arrhythmogenic? J Mol Cell Cardiol (1975) 0.83
Multiple serous effusions complicating pre-eclampsia. A case report. S Afr Med J (1978) 0.82
The value of routine computed tomography scanning of the chest in patients presenting with supradiaphragmatic Hodgkin's disease. Australas Radiol (1993) 0.81
Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heart. Fed Proc (1983) 0.81
Comparison of drugs used in management of arrhythmias developing after acute myocardial infarction. Br Heart J (1969) 0.80
Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant. Arthritis Rheum (1988) 0.80
Renin in the diagnosis of renovascular hypertension. Activity in renal and peripheral vein plasma. JAMA (1967) 0.80
Amiodarone: its side effects, adverse reactions and dosage schedules. N Z Med J (1982) 0.79
Significance of idioventricular rhythms in acute myocardial infarction. Prog Cardiovasc Dis (1974) 0.79
Sinus rate in acute myocardial infarction. Br Heart J (1972) 0.79
Metabolic basis of increased vulnerability to fibrillation in myocardial ischaemia. J Mol Cell Cardiol (1987) 0.78
Beneficial effect of labetalol in hypertensive patients with angina pectoris. S Afr Med J (1983) 0.78
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol. Br J Clin Pharmacol (1982) 0.78
Antiphospholipid antibodies and pregnancy. N Engl J Med (1985) 0.78
Q fever endocarditis: a report of 2 cases. S Afr Med J (1978) 0.77
Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade. Clin Sci Mol Med Suppl (1978) 0.77
Clinical usefulness of the beta-adrenergic antagonists. S Afr Med J (1978) 0.77
The acquired immunodeficiency syndrome in Auckland in 1985. N Z Med J (1986) 0.76
Corticosteroid treatment of pregnant women with antiphospholipid antibodies and previous fetal loss. Am J Obstet Gynecol (1990) 0.75
Improving medical meetings. IV--Evaluate for the future. Br Med J (Clin Res Ed) (1983) 0.75
Cardiac actions of adenosine. Methods Find Exp Clin Pharmacol (1984) 0.75
Antiarrhythmic action of labetalol and its effect on adenine metabolism in the isolated rat heart. J Am Coll Cardiol (1983) 0.75
More on beta-blockers in pregnancy. N Engl J Med (1982) 0.75
Use of diltiazem during pregnancy. N Z Med J (1987) 0.75
The use of captopril in pregnancy. N Z Med J (1983) 0.75
Diuretics in pregnancy associated hypertension. N Z Med J (1983) 0.75
Clonidine in the management of uncontrolled hypertension. S Afr Med J (1974) 0.75
High-precision measurement of 235U ground-state hyperfine structure of laser-rf double resonance. Opt Lett (1979) 0.75
High-precision measurement of the hyperfine structure of the 620-cm-1 metastable atomic level of 235U by laser-rf double resonance. Opt Lett (1979) 0.75
Coronary care units. N Z Med J (1971) 0.75
Lipoid nephrosis and focal glomerulosclerosis. Pathology (1978) 0.75
Hepatic and splenic haemorrhage as a complication of toxaemia of pregnancy in a patient with circulating lupus anticoagulant. N Z Med J (1982) 0.75
Catapres-TTS: a two year posttrial followup. N Z Med J (1988) 0.75
The management of hypertension in pregnancy. S Afr Med J (1981) 0.75
Renin and hypertension--a story of disillusionment. S Afr Med J (1978) 0.75
What has the baboon to offer as a model of experimental ischemia? Eur Heart J (1983) 0.75
Antihypertensive therapy with timolol and alpha-methyldopa. A double-blind trial in patients with moderately severe hypertension. S Afr Med J (1976) 0.75
Fluid compartments in hypertension. S Afr Med J (1978) 0.75
Involvement of an enchondroma in relapsing polychondritis. J Rheumatol (1996) 0.75
Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart failure in patients with acute myocardial infarction. J Physiol (1969) 0.75
Ultrasensitive detection of cs vapor by intracavity laser quenching. Appl Opt (1974) 0.75
Antiarrhythmic actions of nifedipine in acute myocardial ischemia. Am Heart J (1983) 0.75
Sporadic non-African Burkitt's lymphoma. A case report. Australas Radiol (1988) 0.75
Permissive action of potassium on arrhythmogenesis in the rat heart. J Mol Cell Cardiol (1986) 0.75
Antihypertensive treatment and fetal welfare in essential hypertension in pregnancy: a retrospective survey of experience with various regimes at National Women's Hospital, Auckland, 1970-80. N Z Med J (1982) 0.75
Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy. N Z Med J (1987) 0.75
Effect of substrate on enzyme release after coronary artery ligation in isolated rat heart. Recent Adv Stud Cardiac Struct Metab (1975) 0.75
Serum myoglobin, creatine kinase and creatine kinase-MB as mutually supportive indices of myocardial infarction and infarct size. Aust N Z J Med (1982) 0.75
Prazosin in the therapy of uncontrolled hypertension. S Afr Med J (1977) 0.75
Prostacyclin and maternal lupus anticoagulant. Lancet (1984) 0.75
World hypertension project, 1978. S Afr Med J (1978) 0.75
Long-term tolerance of amiodarone treatment for cardiac arrhythmias. Am J Cardiol (1986) 0.75
Evidence for role of cyclic AMP as second messenger of arrhythmogenic effects of beta-stimulation. Adv Cyclic Nucleotide Res (1980) 0.75
Kaposi's sarcoma in AIDS: the role of radiation therapy. Australas Radiol (1989) 0.75
A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS). N Z Med J (1986) 0.75